Mark Kerr Buys 1,000,000 Shares of Cryosite Limited (ASX:CTE) Stock

Cryosite Limited (ASX:CTE) insider Mark Kerr purchased 1,000,000 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was bought at an average price of A$0.83 ($0.54) per share, for a total transaction of A$830,000.00 ($535,483.87).

Cryosite Stock Performance

The company has a current ratio of 2.32, a quick ratio of 1.76 and a debt-to-equity ratio of 87.26.

Cryosite Company Profile

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries.